Investment banker turned biotech chief executive, Robert Bradway, staked a claim as a savvy dealmaker with Amgen Inc's successful acquisition of Onyx Pharmaceuticals Inc for more than $10 billion. In doing ...
via Business News http://finance.yahoo.com/news/bradways-patient-dealmaking-brings-onyx-231332778.html
0 commentaires:
Enregistrer un commentaire